ContextLogic Newsroom

UBS Adjusts Price Target on LogicBio Therapeutics to $6.30 From $6.10, Maintains Neutral Rating

MT NewswiresAug 12 23:18

UBS Adjusts Price Target on ContextLogic to $6.10 From $5.90, Maintains Neutral Rating

MT NewswiresMay 9 23:05

UBS Adjusts ContextLogic Price Target to $5.90 From $6.50, Maintains Neutral Rating

MT NewswiresApr 29 23:09

UBS Adjusts ContextLogic Price Target to $5 From $4.90, Maintains Neutral Rating

MT NewswiresJan 17 01:33

UBS Adjusts ContextLogic Price Target to $4.90 From $6.50, Maintains Neutral Rating

MT NewswiresNov 11, 2023 00:23

Citigroup Upgrades ContextLogic to Neutral, Raises Price Target to $5.5

BenzingaNov 9, 2023 19:14

ContextLogic Analyst Ratings

BenzingaNov 9, 2023 19:11

Loop Capital Upgrades ContextLogic to Hold, Lowers Price Target to $4

BenzingaNov 8, 2023 18:13

ContextLogic Analyst Ratings

BenzingaNov 8, 2023 18:12

Citigroup Maintains Sell on ContextLogic, Lowers Price Target to $5

BenzingaAug 8, 2023 23:41

ContextLogic Analyst Ratings

BenzingaAug 8, 2023 23:40

Credit Suisse Maintains Outperform on ContextLogic, Lowers Price Target to $7

BenzingaAug 7, 2023 20:03

ContextLogic Analyst Ratings

BenzingaAug 7, 2023 20:03

Loop Capital Markets Reaffirms Their Sell Rating on ContextLogic (WISH)

TipRanksAug 4, 2023 19:55

Loop Capital Downgrades ContextLogic to Sell, Announces $7 Price Target

BenzingaJun 29, 2023 18:41

Credit Suisse Lifts ContextLogic's Price Target to $9 From $4.40, Keeps Outperform Rating

MT NewswiresMay 9, 2023 21:54

Credit Suisse Maintains Outperform on ContextLogic, Raises Price Target to $9

BenzingaMay 9, 2023 19:50

UBS Adjusts ContextLogic Price Target to $7.80 From $8.30, Maintains Neutral Rating

MT NewswiresMay 5, 2023 23:54

UBS Adjusts ContextLogic's Price Target to $0.70 From $0.80, Maintains Neutral Rating

MT NewswiresFeb 28, 2023 01:58

Credit Suisse Lowers ContextLogic's Price Target to $4.40 From $5.70, Keeps Outperform Rating

MT NewswiresFeb 24, 2023 21:31